MX2020011208A - Composiciones de los o-glicosil flavonoides. - Google Patents

Composiciones de los o-glicosil flavonoides.

Info

Publication number
MX2020011208A
MX2020011208A MX2020011208A MX2020011208A MX2020011208A MX 2020011208 A MX2020011208 A MX 2020011208A MX 2020011208 A MX2020011208 A MX 2020011208A MX 2020011208 A MX2020011208 A MX 2020011208A MX 2020011208 A MX2020011208 A MX 2020011208A
Authority
MX
Mexico
Prior art keywords
compositions
composition
glycosyl
arginine
flavonoids
Prior art date
Application number
MX2020011208A
Other languages
English (en)
Inventor
Naoto Yamaguchi
Hiroaki Kida
Original Assignee
Alps Pharmaceutical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alps Pharmaceutical Ind Co Ltd filed Critical Alps Pharmaceutical Ind Co Ltd
Publication of MX2020011208A publication Critical patent/MX2020011208A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composicion que contiene L-arginina y un compuesto de glicosilo de formula (I): (ver fórmula) (I), en donde R es un resto formado por un monosacarido, un disacarido o un oligosacárido que incluye de tres a cinco monosacaridos; y la composicion contiene el compuesto de glicosilo y L-arginina en una relacion molar de 1:1.6 a 1:3.0. Tambien se describe un metodo para preparar tal composicion, asi como una composicion preparada mediante el metodo.
MX2020011208A 2018-04-23 2019-04-23 Composiciones de los o-glicosil flavonoides. MX2020011208A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862661255P 2018-04-23 2018-04-23
US201862720651P 2018-08-21 2018-08-21
PCT/JP2019/017262 WO2019208574A1 (en) 2018-04-23 2019-04-23 Compositions of o-glycosyl flavonoids

Publications (1)

Publication Number Publication Date
MX2020011208A true MX2020011208A (es) 2021-01-08

Family

ID=66589824

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011208A MX2020011208A (es) 2018-04-23 2019-04-23 Composiciones de los o-glicosil flavonoides.

Country Status (9)

Country Link
US (1) US11266671B2 (es)
EP (1) EP3752162A1 (es)
JP (1) JP6764206B2 (es)
CN (1) CN112218641A (es)
BR (1) BR112020021788A8 (es)
CA (1) CA3098108C (es)
MX (1) MX2020011208A (es)
TW (1) TWI761672B (es)
WO (1) WO2019208574A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI761672B (zh) 2018-04-23 2022-04-21 日商阿爾卑斯藥品工業股份有限公司 O-醣苷基類黃酮之組成物
US10617705B1 (en) * 2019-01-24 2020-04-14 Alps Pharmaceutical Ind. Co., Ltd. Isoquercitrin compositions
US10918654B1 (en) * 2019-09-23 2021-02-16 Alps Pharmaceutical Ind. Co., Ltd. Rutin compositions
US11110109B2 (en) * 2019-10-22 2021-09-07 Alps Pharmaceutical Ind. Co., Ltd. Water soluble O-glycosyl flavonoid compositions and methods for preparing same
JP7565207B2 (ja) 2020-12-16 2024-10-10 株式会社ファンケル カルノシン酸含有固体組成物及びカルノシン酸の溶出促進方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2451772A (en) 1946-12-27 1948-10-19 Univ Temple Solubilization of rutin with methyl glucamine
US2646428A (en) 1949-09-20 1953-07-21 Dausse Lab Rutin derivatives and production thereof
US2975168A (en) 1957-07-04 1961-03-14 Zyma Sa Process of preparation of a tri-(hydroxyethyl) ether of rutin
US4285964A (en) 1979-08-30 1981-08-25 Continental Pharma Salts of (+)-catechine, their preparation and use, and compositions containing these salts
EP0075626A1 (en) 1981-09-29 1983-04-06 American Cyanamid Company Novel rutin nona- and deca(H-)sulfate salts, methods of preparing novel salts, and use of novel salts of complement inhibitors
JPS59232054A (ja) * 1983-06-14 1984-12-26 Nippon Shokuhin Kako Kk 健康飲食品の製造方法
GB8628228D0 (en) 1986-11-26 1986-12-31 Inst Biolog Morya Dalnevostoch Composition inhibiting pathological addiction to alcohol
JP2926411B2 (ja) 1989-03-08 1999-07-28 株式会社林原生物化学研究所 α―グリコシル ルチンの製造方法とその用途
JP3212706B2 (ja) * 1992-08-05 2001-09-25 日本食品化工株式会社 飲食物
EP0960572A1 (en) 1998-05-12 1999-12-01 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
EP1105121A1 (en) 1998-08-27 2001-06-13 MERCK PATENT GmbH Ascorbate-isoquercetin compositions
DK1161228T3 (da) 1999-03-16 2003-11-24 Merck Patent Gmbh Præparat omfattende isoquercetin og ascorbinsyre i en sustained release-form
JP2003171274A (ja) 2001-12-07 2003-06-17 Tomihiko Higuchi 薬剤耐性菌感染症治療のための医薬組成物および消毒剤
US20060099239A1 (en) 2002-04-15 2006-05-11 Coleman Henry D Dietary supplement for promoting removal of heavy metals from the body
US20040229825A1 (en) * 2003-05-13 2004-11-18 Tomihiko Higuchi Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant
DE10321725A1 (de) * 2003-05-14 2004-12-02 Mucos Pharma Gmbh & Co Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke
US7691425B2 (en) 2003-09-29 2010-04-06 San-Ei Gen F.F.I., Inc. Method for manufacturing α-glycosylisoquercitrin, intermediate product and by-product thereof
JP2005198642A (ja) 2003-12-15 2005-07-28 Yutaka Miyauchi 柑橘類の果皮を原材料とする液状飲用物
US20050148907A1 (en) * 2003-12-24 2005-07-07 Gregory Skover Treatment of skin using a benefit agent and an apparatus
US20060083727A1 (en) * 2004-07-15 2006-04-20 Nanobac Pharmaceuticals, Inc. Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation
WO2006070883A1 (ja) 2004-12-28 2006-07-06 Suntory Limited クエルセチン配糖体組成物およびその調製方法
US20090149481A1 (en) 2005-07-04 2009-06-11 Tokyo Medical And Dental University Pharmaceutical composition and beverage composition comprising l-arginine
WO2007114304A1 (ja) 2006-03-29 2007-10-11 San-Ei Gen F.F.I., Inc. ベンゼン生成抑制剤およびベンゼン生成抑制方法
JP4914758B2 (ja) 2006-05-09 2012-04-11 花王株式会社 液体調味料
JP4790561B2 (ja) * 2006-10-12 2011-10-12 東洋精糖株式会社 フラボノイド組成物、その製造方法および用途
EP2167043A4 (en) 2007-06-06 2013-05-01 Univ South Florida NEW USE CO-CRYSTAL COMPOSITIONS
US20090082400A1 (en) * 2007-07-31 2009-03-26 Ving Lee Soluble pyrone analogs methods and compositions
DE202008006741U1 (de) 2008-05-19 2009-10-01 Langhoff, Gertrud Nährstoffzusammensetzung zur Vitalisierung
CZ300846B6 (cs) 2008-06-26 2009-08-26 Agra Group, A. S. Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy
WO2009158031A2 (en) 2008-06-27 2009-12-30 Limerick Biopharma, Inc. Methods and compositions for therapeutic treatment
CN101301477B (zh) * 2008-07-04 2010-06-09 山西大学 异槲皮苷包合物及其制备方法
JPWO2010029913A1 (ja) 2008-09-11 2012-02-02 株式会社林原生物化学研究所 気力改善剤
US9034834B2 (en) 2008-11-04 2015-05-19 Vymedic, Llc Antiviral supplement formulations
JP2010126503A (ja) 2008-11-28 2010-06-10 Yamano:Kk Ｌ−アスコルビン酸の安定化方法、調製液体抽出物、固体状抽出物、半流動体抽出物
JP5002072B2 (ja) 2009-03-25 2012-08-15 三栄源エフ・エフ・アイ株式会社 水易溶性イソクエルシトリン組成物
JP2010248148A (ja) 2009-04-17 2010-11-04 Rohto Pharmaceut Co Ltd アドバンスド・グリケーション・エンド・プロダクツ分解剤
WO2011104667A1 (en) * 2010-02-25 2011-09-01 Anthem Biosciences Private Limited Basic aminoacid salts of polyphenols
US10391096B2 (en) 2011-10-13 2019-08-27 Quercegen Pharmaceuticals Llc Method for treating thrombotic disorders using quercetin-containing compositions
RU2545905C1 (ru) * 2013-12-16 2015-04-10 Гарри Захарович Казиев Водорастворимая фармацевтическая композиция l-аргинин-дигидрокверцетин и способ ее получения
JP6378513B2 (ja) 2014-03-24 2018-08-22 アサヒ飲料株式会社 ヘスペリジン含有飲料、苦味改善剤及び苦味改善方法
JP2015208241A (ja) 2014-04-24 2015-11-24 三栄源エフ・エフ・アイ株式会社 健康食品
CN108601385A (zh) * 2015-12-04 2018-09-28 三荣源有限公司 酶修饰的异槲皮苷的用途
JP6880757B2 (ja) 2016-01-22 2021-06-02 大正製薬株式会社 経口液体組成物
CN110462052A (zh) 2017-07-28 2019-11-15 太阳化学株式会社 黄酮包合化合物的制造方法
US10603302B2 (en) 2017-08-23 2020-03-31 Roman Aleksandrovich Water soluble flavonoids
TWI761672B (zh) 2018-04-23 2022-04-21 日商阿爾卑斯藥品工業股份有限公司 O-醣苷基類黃酮之組成物
US11446319B2 (en) 2018-06-01 2022-09-20 Taiyo Kagaku Co., Ltd. Composition containing flavonoid-cyclodextrin clathrate compound

Also Published As

Publication number Publication date
CA3098108C (en) 2023-01-10
CA3098108A1 (en) 2019-10-31
WO2019208574A1 (en) 2019-10-31
EP3752162A1 (en) 2020-12-23
TW201943415A (zh) 2019-11-16
CN112218641A (zh) 2021-01-12
BR112020021788A2 (pt) 2021-05-04
US11266671B2 (en) 2022-03-08
TWI761672B (zh) 2022-04-21
BR112020021788A8 (pt) 2022-12-20
JP6764206B2 (ja) 2020-09-30
JP2020524130A (ja) 2020-08-13
US20210379093A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
MX2020011208A (es) Composiciones de los o-glicosil flavonoides.
MX2013014265A (es) Glicolipidos de cadena larga utiles para evitar el deterioro o la contaminacion microbiana de materiales.
MX2009007415A (es) Sacaridos modificados.
MX344054B (es) Composicion de oligosacaridos y galactosacaridos de la leche para formula para lactantes que contiene la fraccion soluble de oligosacaridos presente en la leche y que tiene un bajo nivel de monosacaridos y un proceso para producir la composicion.
IL189156A (en) A bite-containing (theo-hydrazide-rich) preparation, a flake cation and a thickening additive, a method for making this lipophilate and the leophilizate
MY193955A (en) Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility
PH12015502514A1 (en) An amorphous and crystalline form of genz 112638 hemitartrat as inhibitor of glucosylceramide synthase
TW200806328A (en) One-part hair dye composition
NZ593882A (en) Process for the synthesis of l-fucosyl di- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof
MY158326A (en) Glycoside derivatives and uses thereof
NZ590306A (en) Compound comprising a mineral-amino acid conjugated to a polysaccharide and process for its preparation
NO20083590L (no) Biocidblandinger inneholdende pyrition- og pyrrolderivativer
WO2009046314A3 (en) Moenomycin analogs, methods of synthesis, and uses thereof
GEP20094822B (en) Intermediate and process for preparing of beta- anomer enriched 21-deoxy, 21, 21-difluoro-d-ribofuranosyl nucleosides
MX2022000996A (es) Nuevo glucosido de esteviol, metodo para su produccion y composicion endulzante que contiene al mismo.
BRPI0605508A (pt) métodos para estabilização de composições oftálmicas
TW200833371A (en) Process for solid formulations
MY192148A (en) Steviol glycoside composition
BRPI0519819A2 (pt) composição aquosa de amaciamento de tecidos
AR057555A1 (es) Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
IL198848A (en) Sodium salt of a disaccharide compound, a method of manufacture and use thereof
EP1849467A4 (en) SYNERGIC PHARMACEUTICAL PREPARATION CONTAINING BAICALEIN AND BAICALIN AND INTENDED FOR INHIBITION OF A TUMOR
BR112014004267A2 (pt) derivado de ácido pirrolidina-3-ilacético
BR112014016423A8 (pt) composição de controle de doença de planta
WO2008007003A3 (fr) Nouveaux derives de sucre, procede pour leur preparation et leur utilisation comme agents tensioactifs